Kayne Anderson Rudnick Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.71M | Buy |
8,970
+404
| +5% | +$212K | 0.01% | 266 |
|
|
2025
Q1 | $5.43M | Buy |
8,566
+3,288
| +62% | +$2.09M | 0.01% | 267 |
|
|
2024
Q4 | $3.76M | Sell |
5,278
-468
| -8% | -$333K | 0.01% | 288 |
|
|
2024
Q3 | $6.04M | Buy |
5,746
+89
| +2% | +$93.6K | 0.01% | 263 |
|
|
2024
Q2 | $5.95M | Buy |
5,657
+1,263
| +29% | +$1.33M | 0.01% | 271 |
|
|
2024
Q1 | $4.23M | Buy |
4,394
+280
| +7% | +$270K | 0.01% | 298 |
|
|
2023
Q4 | $3.61M | Sell |
4,114
-156
| -4% | -$137K | 0.01% | 307 |
|
|
2023
Q3 | $3.51M | Sell |
4,270
-32
| -0.7% | -$26.3K | 0.01% | 313 |
|
|
2023
Q2 | $3.09M | Buy |
+4,302
| New | +$3.09M | 0.01% | 322 |
|
|
2022
Q2 | – | Sell |
-3
| Closed | -$2K | – | 668 |
|
|
2022
Q1 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 601 |
|
|
2020
Q3 | – | Sell |
-7
| Closed | -$4K | – | 577 |
|
|
2020
Q2 | $4K | Hold |
7
| – | – | ﹤0.01% | 472 |
|
|
2020
Q1 | $3K | Sell |
7
-4
| -36% | -$1.71K | ﹤0.01% | 500 |
|
|
2019
Q4 | $4K | Buy |
11
+4
| +57% | +$1.46K | ﹤0.01% | 493 |
|
|
2019
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 522 |
|
|
2019
Q2 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 512 |
|